Objective-To assess the accuracy of four enzymatic tests, including early release rates of creatine kinase and a-hydroxybutyrate dehydrogenase, in assessing coronary reperfusion after thrombolytic therapy.
Thrombolytic therapy for acute myocardial infarction is used to achieve reperfusion of the infarct related coronary artery. Intracoronary thrombolysis needs emergency cardiac catheterisation and so is of limited value. This has led to widespread use of intravenous administration of thrombolytic drugs. Hence, reliable methods, other than angiographic evidence, are needed to detect coronary reperfusion. In previous studies, relief of chest pain, 13 resolution of ST segment elevations,45 and occurrence of specific arrhythmias' were used as markers of reperfusion. Also, after reperfusion of an acutely occluded coronary artery early peaking of plasma creatine kinase and creatine kinase MB activity"'2 as well as other cardiac enzymes'314 were found. These noninvasive criteria are neither sensitive nor specific, however, as indicators of recanalisation. 5 16 Even when they are used in combination, their predictive accuracy is high only when they are concordant. Unfortunately, concordance occurs in only 14% of patients with reperfusion and in 79% of patients without. ' 5 Recently, several investigators have evaluated the rapid initial increases in plasma creatine kinase and creatine kinase MB activity as non-angiographic markers of reperfusion.'7"9 The onset of these increases closely reflected the time of angiographic documentation of reperfusion. As indicators of coronary artery reperfusion they seemed to be highly sensitive and specific.
Analogous to this rapid initial increase in plasma creatine kinase activity another enzymatic marker of reperfusion could be the rapid initial increase in plasma activity of ahydroxybutyrate dehydrogenase. To determine the accuracy of enzymatic tests in assessing coronary reperfusion we compared four different enzymatic variables: (1) the time to peak creatine kinase activity; (2) the early release rate of creatine kinase activity; (3) the early release rate of a-hydroxybutyrate dehydrogenase; and (4) the rate of ahydroxybutyrate dehydrogenase release represented by the ratio of quantities released in 24 hours and 72 hours. The diagnostic effectiveness and efficiency of these tests were evaluated by cumulative distribution analysis graphs' (as an alternative to receiver operating characteristic curves2') and decision level curves.22
Methods

PATIENTS
Patients studied were part of a prospective trial with 201 consecutive patients treated with intravenous and intracoronary streptokinase for acute myocardial infarction according to a standardised protocol (750 000 IU intravenous streptokinase and 250 000 IU intracoronary streptokinase). The aims of this prospective trial were to identify patients with a successful thrombolytic treatment and to study the effects of elective percutaneous transluminal coronary angioplasty (PTCA) which was used for prophylactic reasons after successful thrombolysis. Acute coronary angiography was performed in all patients. Only patients with an occluded infarct related artery before the start of intracoronary streptokinase infusion were included in the present analysis. Two groups of patients were compared: (1) Thus 89 patients formed our study population; 74 showed reperfusion of the infarct related artery after intracoronary streptokinase and 15 showed no reperfusion. Table 1 presents the results of the four enzymatic tests for these patients. Reperfused patients showed a shorter time to peak creatine kinase activity, more rapid early release rates of creatine kinase and a-hydroxybutyrate dehydrogenase and also a higher Q24/Q72 ratio than non-reperfused patients. The differences between groups were highly significant for all enzymatic tests. The enzymatic infarct size as measured by cumulative release of ahydroxybutyrate dehydrogenase during the first 72 hours (Q72) was not different between groups. Figure 1 presents the cumulative distribution analysis graphs for the four enzymatic tests. It seemed that none of the four tests was sufficiently sensitive or specific to assess reperfusion. Using decision level plots, we determined the optimum decision threshold value for all four enzymatic tests and measured sensitivity, specificity, accuracy, and the predictive values of a positive test and a negative test. Accuracy is defined as true positives plus true negatives divided by the number of patients tested. Table 2 summarises the results. Despite optimal cut off values the accuracy of the tests was low with 82% as the highest value for Q4/Q72. The predictive value of a negative test was very low for all tests. The ratio Q4/Q72 had the best predictive value of a negative test (50%). This is still low and not there was an early rapid rate of increase, which then progressively declined. So, with a longer interval between taking the first two blood samples, as in our study, the initial rapid increase rate could be missed. Garabedian et al and Lewis et al also determined the rate of increase in creatine kinase MB activity in the very early phase of reperfusion and found that several empirical estimates of the rate of increase could differentiate between patients with reperfusion and without.7 18 The definition of reperfusion is not the same for all studies mentioned earlier. Garabedian et al defined reperfusion as complete distal opacification of the previously occluded coronary artery (TIMI grade 2 or 3). 17 The same definition was used in our study. This definition includes patients with slow and rapid filling of the distal part of the coronary artery, and hence with slow and rapid appearance patterns of cardiac enzymes. Lewis and coworkers, however, studied only reperfused patients with a complete and rapid filling of the infarct related artery (TIMI grade 3), and they found that the rates of absolute increase in creatine kinase and creatine kinase MB activity completely separated the patients with from the patients without reperfusion.'8 These findings indicate that a rapid initial increase in cardiac enzyme activity in plasma depends upon the re-establishment of perfusion with normal coronary blood flow rather than simply patency of the infarct related artery. Although in our study reperfused patients showed a shorter time to peak creatine kinase activity and more rapid early release rates of creatine kinase and a-hydroxybutyrate dehydrogenase than nonreperfused patients, and the differences reached significance, we could not determine an index of coronary artery reperfusion with plasma enzyme tests that clearly distinguished between reperfused and non-reperfused patients. Even the optimum cut offpoints for the different Cumulative distribution analysis graphs for the four enzyme tests. Table 2 Sensitivity, specificity, accuracy, and predictive values at optimal decision threshold levels offour enzymatic tests for reperfusion applied to patients with acute myocardial infarction having reperfusion (74) and no reperfusion (15) (table 2) , especially for the early release rates of creatine kinase and oa-hydroxybutyrate dehydrogenase, the two tests that will give a result within the first hours of infarction, when rescue PTCA may be considered. In the presence of a low pretest probability of nonreperfusion, enzymatic tests will not discriminate accurately between patients with and without reperfusion of the infarct related coronary artery. It seems likely that other more refined or sophisticated assays, such as those for creatine kinase isoforms, 29 30 have the same limitations in predicting coronary reperfusion because their rate of appearance is affected by the same factors as affect the enzymes we measured.
Possibly the results would have been improved if we had taken blood samples more frequently; however, a high sampling rate makes the test cumbersome in routine clinical practice. It seems that currently only coronary arteriography allows accurate assessment of the perfusion state of the infarct related artery, particularly in the very early stage of myocardial infarction when further interventional procedures may still be beneficial to the patient.
